87 related articles for article (PubMed ID: 7991463)
1. AgNOR content and PCNA expression in transplanted malignant neurinoma in rats.
Mennel HD; Rickert D
Pathol Res Pract; 1994 May; 190(5):423-8. PubMed ID: 7991463
[TBL] [Abstract][Full Text] [Related]
2. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
[TBL] [Abstract][Full Text] [Related]
3. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation in intracranial tumours: selective silver staining of nucleolar organizer regions (AgNORs). Application to surgical and experimental neuro-oncology.
Plate KH; Rüschoff J; Mennel HD
Neuropathol Appl Neurobiol; 1991 Apr; 17(2):121-32. PubMed ID: 1713308
[TBL] [Abstract][Full Text] [Related]
6. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
7. An improved system for quantifying AgNOR and PCNA in canine tumors.
Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
[TBL] [Abstract][Full Text] [Related]
8. [AgNOR analysis of astrocytoma in childhood].
Haberland C; Martin H; Guski H; Hufnagl P; Vogel S
Zentralbl Neurochir; 1996; 57(1):5-11. PubMed ID: 8900893
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
10. Determination of epidermal proliferative activity in experimental mouse tail test by AgNOR analysis.
Heinisch G; Wozel G
Exp Toxicol Pathol; 1995 Jan; 47(1):19-23. PubMed ID: 7719116
[TBL] [Abstract][Full Text] [Related]
11. Expression of silver-stained nucleolar organizer regions is coupled to cell cycle in rat thymic cells.
Carbajo S; Orfao A; Vicente-Villardón JL; Carbajo-Pérez E
Cytometry; 1993; 14(1):46-52. PubMed ID: 8432202
[TBL] [Abstract][Full Text] [Related]
12. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
13. Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma.
Bethwaite PB; Delahunt B; Holloway LJ; Thornton A
Pathology; 1995 Jan; 27(1):1-4. PubMed ID: 7603742
[TBL] [Abstract][Full Text] [Related]
14. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
Derenzini M; Trerè D
Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of AgNOR and PCNA in experimental carcinogenesis of salivary glands of rats.
Ferraris ME; Fonseca M; Gendelman H
Acta Stomatol Belg; 1997 Mar; 94(1):23-7. PubMed ID: 9923107
[TBL] [Abstract][Full Text] [Related]
16. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
[TBL] [Abstract][Full Text] [Related]
17. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
Gulbahar MY; Yuksel H; Guvenc T; Okut H
Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
[TBL] [Abstract][Full Text] [Related]
18. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of proliferation activity in human CNS tumours: the determination of AgNOR, PCNA and Ki-67 expression. Part 1: AgNOR expression in CNS tumours.
Janczukowicz J
Folia Neuropathol; 2003; 41(2):97-101. PubMed ID: 12899202
[TBL] [Abstract][Full Text] [Related]
20. Correlation between PCNA expression and AgNOR dots in pituitary adenomas.
Klencki M; Kurnatowska I; Słowińska-Klencka D; Lewiński A; Pawlikowski M
Endocr Pathol; 2001; 12(2):163-9. PubMed ID: 11579682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
